Wealthcare Capital Management’s Avanos Medical AVNS Stock Holding History

Wealthcare Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4	Closed	–	–	278
2019 Q4	$0	Hold	4	–	–	﹤0.01%	669
2019 Q3	$0	Hold	4	–	–	﹤0.01%	189
2019 Q2	$0	Hold	4	–	–	﹤0.01%	180
2019 Q1	$0	Hold	4	–	–	﹤0.01%	187
2018 Q4	$0	Hold	4	–	–	﹤0.01%	190
2018 Q3	$0	Buy	+4	New	+$257	﹤0.01%	192
2017 Q2	–	Sell	-1	Closed	–	–	180
2017 Q1	$0	Hold	1	–	–	﹤0.01%	189
2016 Q4	$0	Hold	1	–	–	﹤0.01%	188
2016 Q3	$0	Hold	1	–	–	﹤0.01%	199
2016 Q2	$0	Hold	1	–	–	﹤0.01%	201
2016 Q1	$0	Hold	1	–	–	﹤0.01%	212
2015 Q4	$0	Sell	1 -4	-80%	-$124	﹤0.01%	221
2015 Q3	$0	Buy	5 +4	+400%	+$140	﹤0.01%	250
2015 Q2	$0	Sell	1 -278	-100%	-$12.5K	﹤0.01%	416
2015 Q1	$14K	Buy	279 +278	+27,800%	+$12.9K	﹤0.01%	453
2014 Q4	$0	Buy	+1	New	+$39	﹤0.01%	201

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Wealthcare Capital Management's AVNS Position: Q1 2020 in Review

Wealthcare Capital Management sold out of Avanos Medical (AVNS) in Q1 2020, closing a stake of 4 shares.

Wealthcare Capital Management first reported a position in AVNS in Q4 2014 and held it in 16 quarters. The position peaked at $14K in Q1 2015. 272 funds tracked by Wall St. Rank hold AVNS as of Q1 2020.

Wealthcare Capital Management reported no remaining Avanos Medical position as of Q1 2020 after selling out during the quarter.
Wealthcare Capital Management sold 4 Avanos Medical shares in Q1 2020.
Wealthcare Capital Management first reported a position in Avanos Medical in Q4 2014 and held it in 16 quarters.
Wealthcare Capital Management's Avanos Medical position peaked at $14K in Q1 2015.
272 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2020.

Based on Wealthcare Capital Management's 13F filing for Q1 2020, filed 29 Apr 2020.